About Zylö Therapeutics: Zylö has developed the Z-pod™ technology platform, a disruptive topical delivery system that extends the duration of effect, improves the solubility/targeting, and enhances the product performance of many therapeutic and cosmetic agents. Notably, the Z-pod™ technology has successfully harnessed the therapeutic potential of nitric oxide, one of the most powerful-and short-lived-biomolecules produced by our bodies.
| Website | https://zylotherapeutics.com |
| Revenue | $9 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2017 |
| Address | 105a Ben Hamby Rd, Greenville, South Carolina 29615, US |
| Phone | +1 858-775-6710 |
| Industry | Pharmaceuticals, Pharmaceutical, Drug Delivery, Healthcare, Health Care, Therapeutics |
| Keywords | Drug Delivery Systems, Topical Drug Delivery, Innovative Drug Delivery, Targeted Drug Delivery, Controlled Release Technology, Pharmaceutical Development, Local Drug Delivery, Pharmaceutical Research, Therapeutic Solutions, Biotechnology Innovation |
| Competitors | CuraSen Therapeutics, Inc., Axovant Sciences Ltd, Kymab Ltd, Boehringer Ingelheim, NantKwest, Lilly India, Roche, Amgen, Bristol Myers Squibb, Cerus +48 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies |
Looking for a particular Zylö Therapeutics employee's phone or email?
The Zylö Therapeutics annual revenue was $9 million in 2026.
Jay Blankenship is the Vice President of Business Development of Zylö Therapeutics.
3 people are employed at Zylö Therapeutics.
Zylö Therapeutics is based in Greenville, South Carolina.
The NAICS codes for Zylö Therapeutics are [541714, 325, 5417, 54171, 54, 32, 541].
The SIC codes for Zylö Therapeutics are [87, 873].